Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 28340 | 170 | 33.5 | 72% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 545 | 13948 | REBAMIPIDE//GASTRIC MUCOSAL BLOOD FLOW//GASTRIC MUCOSA |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | GERANYLGERANYLACETONE | Author keyword | 15 | 37% | 19% | 33 |
| 2 | TEPRENONE | Author keyword | 12 | 54% | 9% | 15 |
| 3 | GASTRIC MUCOSAL CELL | Author keyword | 3 | 50% | 3% | 5 |
| 4 | TETRAPRENYLACETONE | Author keyword | 3 | 60% | 2% | 3 |
| 5 | GASTRIC MUCOSAL CELLS | Author keyword | 2 | 23% | 5% | 8 |
| 6 | GASTRIC STRESSORS | Author keyword | 1 | 100% | 1% | 2 |
| 7 | LIVER TISSUE BLOOD FLOW | Author keyword | 1 | 100% | 1% | 2 |
| 8 | PIT CELL LINEAGE | Author keyword | 1 | 100% | 1% | 2 |
| 9 | GASTRIC MUCOSAL LESION RAT | Author keyword | 1 | 33% | 2% | 3 |
| 10 | GEFARNATE | Author keyword | 1 | 40% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | GERANYLGERANYLACETONE | 15 | 37% | 19% | 33 | Search GERANYLGERANYLACETONE | Search GERANYLGERANYLACETONE |
| 2 | TEPRENONE | 12 | 54% | 9% | 15 | Search TEPRENONE | Search TEPRENONE |
| 3 | GASTRIC MUCOSAL CELL | 3 | 50% | 3% | 5 | Search GASTRIC+MUCOSAL+CELL | Search GASTRIC+MUCOSAL+CELL |
| 4 | TETRAPRENYLACETONE | 3 | 60% | 2% | 3 | Search TETRAPRENYLACETONE | Search TETRAPRENYLACETONE |
| 5 | GASTRIC MUCOSAL CELLS | 2 | 23% | 5% | 8 | Search GASTRIC+MUCOSAL+CELLS | Search GASTRIC+MUCOSAL+CELLS |
| 6 | GASTRIC STRESSORS | 1 | 100% | 1% | 2 | Search GASTRIC+STRESSORS | Search GASTRIC+STRESSORS |
| 7 | LIVER TISSUE BLOOD FLOW | 1 | 100% | 1% | 2 | Search LIVER+TISSUE+BLOOD+FLOW | Search LIVER+TISSUE+BLOOD+FLOW |
| 8 | PIT CELL LINEAGE | 1 | 100% | 1% | 2 | Search PIT+CELL+LINEAGE | Search PIT+CELL+LINEAGE |
| 9 | GASTRIC MUCOSAL LESION RAT | 1 | 33% | 2% | 3 | Search GASTRIC+MUCOSAL+LESION+RAT | Search GASTRIC+MUCOSAL+LESION+RAT |
| 10 | GEFARNATE | 1 | 40% | 1% | 2 | Search GEFARNATE | Search GEFARNATE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GERANYLGERANYLACETONE | 14 | 44% | 14% | 24 |
| 2 | TETRAPRENYLACETONE | 12 | 75% | 5% | 9 |
| 3 | TEPRENONE | 5 | 63% | 3% | 5 |
| 4 | GASTRIC MUCOSAL CELLS | 4 | 17% | 14% | 24 |
| 5 | CONJUGATING ENZYMES UBC4 | 1 | 50% | 1% | 1 |
| 6 | MICROVASCULAR ACTIONS | 1 | 50% | 1% | 1 |
| 7 | PREPYLORIC ULCER | 1 | 50% | 1% | 1 |
| 8 | GASTROINTESTINAL PATHOPHYSIOLOGY | 0 | 33% | 1% | 1 |
| 9 | GERANYLGERANYLACETONE PROTECTS | 0 | 33% | 1% | 1 |
| 10 | IRRITANT INDUCED APOPTOSIS | 0 | 33% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| HSP-Dependent Protection Against Gastrointestinal Diseases | 2010 | 9 | 47 | 30% |
| Identification of Molecular Mechanism for Actions of Existing Medicines and Its Application for Drug Development | 2012 | 0 | 24 | 58% |
| BIOLOGICALLY-ACTIVE DERIVATIVES OF POLYPRENYLACETIC ACIDS AND THEIR RELATED-COMPOUNDS (A REVIEW) | 1990 | 1 | 10 | 60% |
| Drug discovery and development focusing on existing medicines: drug re-profiling strategy | 2011 | 8 | 40 | 33% |
| A strategy for development of NSAIDs with lower risk for side effects | 2008 | 3 | 13 | 46% |
| Isoprenoids: Remarkable diversity of form and function | 2004 | 65 | 221 | 4% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GRP HOSP UNIV COCHIN PORT ROYAL | 1 | 50% | 0.6% | 1 |
| 2 | P INFECT ONCOL | 1 | 29% | 1.2% | 2 |
| 3 | ADV GASTROENTEROL | 0 | 33% | 0.6% | 1 |
| 4 | ZHEJIANG HOSP 1 | 0 | 33% | 0.6% | 1 |
| 5 | ANESTHESIOL CRITICAL CARE MED | 0 | 25% | 0.6% | 1 |
| 6 | GASTROENTEROL TRADIT CHINESE MED | 0 | 25% | 0.6% | 1 |
| 7 | HEALTHCARE TECHNOL ASSESSMENT | 0 | 20% | 0.6% | 1 |
| 8 | MOL MED ADULT GERIATR DIS | 0 | 17% | 0.6% | 1 |
| 9 | KUNHUA AFFILIATED HOSP | 0 | 13% | 0.6% | 1 |
| 10 | EA4589 | 0 | 10% | 0.6% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000283106 | Z 103//CAS 107667 60 7//POLAPREZINC |
| 2 | 0.0000194768 | REBAMIPIDE//CAS 11911 87 6//QUALITY OF ULCER HEALING |
| 3 | 0.0000190766 | CS 670//LOXOPROFEN//ALPHA BETA KETOALKENE |
| 4 | 0.0000185504 | EBROTIDINE//SOFALCONE//SULGLYCOTIDE |
| 5 | 0.0000175400 | GASTROPROTECTION//GASTRIC ULCER//GASTROPROTECTIVE |
| 6 | 0.0000156353 | DIAPHRAGM DISEASE//SMALL INTESTINAL INJURY//SMALL INTESTINAL DAMAGE |
| 7 | 0.0000132075 | PHARMACOL CARDIOVASC EXPT BIOMOL//CRIT CARE MED OSB5//HEAT STRESS PROTEIN |
| 8 | 0.0000108699 | GASTRIC ANTRAL VASCULAR ECTASIA//WATERMELON STOMACH//PORTAL HYPERTENSIVE GASTROPATHY |
| 9 | 0.0000102486 | LAFUTIDINE//CAPSAICIN SENSITIVE SENSORY NEURON//GASTRIC MUCIN BIOSYNTHESIS |
| 10 | 0.0000092859 | HSP70 MESSENGER RNA//HEAT SHOCK COGNATE PROTEIN//BRAIN ISCHEMIA AND REPERFUSION |